{"id":69005,"date":"2026-03-13T11:51:26","date_gmt":"2026-03-13T11:51:26","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=69005"},"modified":"2026-10-15T10:33:59","modified_gmt":"2026-10-15T10:33:59","slug":"cjc-1295-without-dac","status":"publish","type":"product","link":"https:\/\/medsbase.com\/es\/product\/cjc-1295-without-dac\/","title":{"rendered":"CJC-1295 sin DAC"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Respuesta r\u00e1pida \u2014 \u00bfQu\u00e9 es el CJC-1295 sin DAC?<\/h3>\n<p style=\"margin: 0;\"><strong>CJC-1295 sin DAC<\/strong> (tambi\u00e9n llamado <strong>Mod GRF 1-29<\/strong>) es un an\u00e1logo sint\u00e9tico modificado de GHRH (1-29) con una vida media plasm\u00e1tica corta de ~30 minutos. A diferencia de la versi\u00f3n con DAC, carece de la uni\u00f3n a alb\u00famina, produciendo una <strong>puls\u00e1til<\/strong> rather than sustained GH signal. This kinetic profile makes it the preferred tool when pulse-timing matters. Supplied in 2\u00a0mg to 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Qu\u00e9 obtienes con MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/es\/reviews\/\">opiniones de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada pedido est\u00e1 cubierto por nuestra <a href=\"https:\/\/medsbase.com\/es\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 si tu paquete no llega en 20 d\u00edas laborables, lo reenviamos.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especificaci\u00f3n<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalle<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">863288-34-0 (parental) \u00b7 446262-90-4 (forma Mod-GRF 1\u201329 ampliamente citada)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>152<\/sub>H<sub>252<\/sub>N<sub>44<\/sub>O<sub>42<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">3367.92 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Secuencia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">D-Ala-Tyr-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH<sub>2<\/sub> (Mod-GRF 1\u201329, sin enlazador DAC)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Polvo liofilizado (o seg\u00fan suministro)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificado por HPLC, COA bajo solicitud)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Almacenamiento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (refrigerador) para stock de trabajo; \u221220 \u00b0C para almacenamiento a largo plazo de viales sin abrir. Reconstituido: 2\u20138 \u00b0C, usar dentro de ~30 d\u00edas. Proteger de la luz. No congelar-descongelar la soluci\u00f3n reconstituida.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidad<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Agua bacteriost\u00e1tica (recomendada) o agua est\u00e9ril para periodos de uso m\u00e1s cortos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>\u00bfQu\u00e9 es el CJC-1295 sin DAC?<\/h2>\n<p><strong>CJC-1295 sin DAC<\/strong> (com\u00fanmente llamado <strong>Mod GRF 1-29<\/strong> o simplemente <strong>GRF 1-29 tetrasustituido<\/strong>) es un an\u00e1logo sint\u00e9tico de 30 amino\u00e1cidos de la hormona liberadora de hormona de crecimiento. Comparte la misma secuencia pept\u00eddica central que <a href=\"https:\/\/medsbase.com\/es\/cjc-1295-with-dac\/\">CJC-1295 con DAC<\/a> \u2014 cuatro sustituciones de amino\u00e1cidos en la secuencia nativa de GHRH (1-29) proporcionan resistencia a la escisi\u00f3n por DPP-IV \u2014 pero <strong>carece de la modificaci\u00f3n DAC de uni\u00f3n a alb\u00famina<\/strong> that extends half-life in the &#8220;with DAC&#8221; version. The practical consequence of no DAC: plasma half-life remains in the minutes-to-hours range (~30 minutes) rather than days. Study protocols therefore use multiple daily injections (typically 2\u20133x) to maintain GHRH signal rather than the weekly dosing of the DAC version. This mimics the short, pulsatile profile of endogenous GHRH and is the preferred tool when pulse-timing matters \u2014 particularly in protocols studying physiological GH pulsatility alongside ghrelin-receptor agonists such as <a href=\"https:\/\/medsbase.com\/es\/ipamorelin\/\">ipamorelin<\/a>. Molecular weight approximately 3,367\u00a0Da. Supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. For mechanism, context, and stacking protocols, see our <a href=\"https:\/\/medsbase.com\/es\/ipamorelin-cjc-1295-stack-guide\/\">Ipamorelin &amp; CJC-1295 guide<\/a>. <\/p>\n<h2>Mecanismo de acci\u00f3n \u2014 Se\u00f1alizaci\u00f3n puls\u00e1til de GHRH<\/h2>\n<p>El Mod GRF 1-29 act\u00faa a trav\u00e9s de la misma v\u00eda del receptor de GHRH hipofisario que el GHRH nativo, pero con un perfil cin\u00e9tico que lo distingue tanto del GHRH nativo como de la versi\u00f3n con DAC:<\/p>\n<ul>\n<li><strong>Agonismo del receptor de GHRH<\/strong> \u2014 El CJC-1295 sin DAC se une a los receptores de GHRH en los somatotropos hipofisarios, estimulando la s\u00edntesis y liberaci\u00f3n de hormona de crecimiento. Las sustituciones de amino\u00e1cidos resisten la degradaci\u00f3n por DPP-IV, proporcionando una actividad m\u00e1s prolongada que el GHRH nativo (que dura solo unos minutos) pero a\u00fan dentro del rango de vida media corta de 30 minutos.<\/li>\n<li><strong>Cin\u00e9tica puls\u00e1til corta<\/strong> \u2014 al no haber una uni\u00f3n a la alb\u00famina, los niveles plasm\u00e1ticos aumentan y disminuyen en una escala temporal que coincide con la arquitectura natural de los pulsos de GH. Esta es la distinci\u00f3n mec\u00e1nica cr\u00edtica respecto a la versi\u00f3n DAC, que produce una elevaci\u00f3n sostenida no puls\u00e1til.<\/li>\n<li><strong>Sinergia con GHRP mediante receptor paralelo<\/strong> \u2014 la coadministraci\u00f3n con un p\u00e9ptido liberador de hormona del crecimiento como <a href=\"https:\/\/medsbase.com\/es\/ipamorelin\/\">ipamorelin<\/a> (acting on the parallel ghrelin-receptor pathway) produces GH pulses substantially larger than either compound alone. The short-half-life version is often preferred for this stacking studies because both peptides can be timed together for same-pulse amplification.<\/li>\n<\/ul>\n<p>The studies implication: Mod GRF 1-29 is the tool of choice when the studies question involves <em>se\u00f1alizaci\u00f3n fisiol\u00f3gica puls\u00e1til de GH<\/em>. La versi\u00f3n DAC se prefiere cuando la pregunta implica <em>elevaci\u00f3n sostenida de GH\/IGF-1<\/em>. Misma familia de p\u00e9ptidos; farmacocin\u00e9tica fundamentalmente diferente. <\/p>\n<h2>Published Evidence<\/h2>\n<p>CJC-1295 without DAC is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Liberaci\u00f3n puls\u00e1til de GH<\/strong> \u2014 physiological GH-pulse support matching native GHRH kinetics<\/li>\n<li><strong>Combinaci\u00f3n con Ipamorelina<\/strong> \u2014 the canonical GHRH + GHRP studies combination, often using the short-half-life variant for same-pulse timing<\/li>\n<li><strong>Body composition studies<\/strong> \u2014 lean-mass, IGF-1 response, and body-composition studies in pulsatile GH-axis modulation studies<\/li>\n<li><strong>Arquitectura del sue\u00f1o<\/strong> \u2014 pre-sleep dosing aligned with endogenous nocturnal GH-surge studies<\/li>\n<li><strong>Recovery studies<\/strong> \u2014 protocolos de recuperaci\u00f3n muscular esquel\u00e9tica combinados con <a href=\"https:\/\/medsbase.com\/es\/bpc-157\/\">BPC-157<\/a> y <a href=\"https:\/\/medsbase.com\/es\/tb-500\/\">TB-500<\/a> for connective-tissue and muscle studies<\/li>\n<li><strong>Comparative kinetic studies<\/strong> \u2014 en comparaci\u00f3n directa con <a href=\"https:\/\/medsbase.com\/es\/cjc-1295-with-dac\/\">CJC-1295 con DAC<\/a> para aislar el efecto de la uni\u00f3n a alb\u00famina en la se\u00f1alizaci\u00f3n del eje GH<\/li>\n<li><strong>Comparaciones de an\u00e1logos de GHRH<\/strong> \u2014 junto con <a href=\"https:\/\/medsbase.com\/es\/sermorelin-peptide-guide\/\">sermorelina<\/a> y <a href=\"https:\/\/medsbase.com\/es\/tesamorelin-peptide-guide\/\">tesamorelina<\/a> for cross-analog pharmacology studies<\/li>\n<\/ul>\n<p>Para un contexto m\u00e1s amplio sobre p\u00e9ptidos del eje GH, consulte el <a href=\"https:\/\/medsbase.com\/es\/peptides\/\">cat\u00e1logo de p\u00e9ptidos<\/a>. <\/p>\n<h2>Concentraciones y potencias disponibles<\/h2>\n<p>MedsBase dispone de CJC-1295 sin DAC en los siguientes tama\u00f1os de viales liofilizados:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Potencia del vial<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tama\u00f1os de paquete<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>2 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Dosificaci\u00f3n piloto, titulaci\u00f3n o protocolos cortos<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 supports ~50 administrations at 100 mcg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Protocolos extendidos, dosificaci\u00f3n m\u00faltiple diaria, menor coste por mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Because Mod GRF 1-29 is typically dosed 2\u20133x daily at 100\u2013200\u00a0mcg per administration, a 5\u00a0mg vial supports 2\u20133 weeks of use. All strengths are supplied as lyophilized powder at 99%+ HPLC purity. <\/p>\n<h2>C\u00f3mo se comparan \u2014 CJC-1295 sin DAC vs con DAC vs Ipamorelina<\/h2>\n<p>Los tres p\u00e9ptidos del eje GH difieren significativamente en receptor, vida media y caracter\u00edsticas de combinaci\u00f3n:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">CJC-1295 sin DAC<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">CJC-1295 con DAC<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Ipamorelina<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Clase<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">An\u00e1logo de GHRH (vida media corta)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">An\u00e1logo de GHRH (vida media prolongada)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">GHRP (receptor de ghrelina)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Vida media<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~30 minutos<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~7 d\u00edas (unido a alb\u00famina)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~2 horas<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Perfil de GH<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Puls\u00e1til, fisiol\u00f3gico<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Elevaci\u00f3n sostenida<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">R\u00e1faga puls\u00e1til<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dosis t\u00edpica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100\u2013200 mcg, 2\u20133 veces al d\u00eda<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\u20132 mg semanal<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">200\u2013300 mcg, 2\u20133 veces al d\u00eda<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Ideal use<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pulse-timing studies, same-pulse stacking<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sustained IGF-1 studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Emparejamiento can\u00f3nico con CJC-1295<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Comparaci\u00f3n completa de protocolos en nuestro <a href=\"https:\/\/medsbase.com\/es\/ipamorelin-cjc-1295-stack-guide\/\">Ipamorelin + CJC-1295 guide<\/a>. <\/p>\n<h2>Almacenamiento y reconstituci\u00f3n<\/h2>\n<p><strong>Antes de la reconstituci\u00f3n:<\/strong> almacene los viales liofilizados refrigerados a 2\u20138 \u00b0C en su envase original, estables hasta 36 meses. Evite los ciclos de congelaci\u00f3n-descongelaci\u00f3n en el polvo. <strong>Procedimiento de reconstituci\u00f3n:<\/strong> inyectar agua bacteriost\u00e1tica por la pared lateral del vial de p\u00e9ptidos seg\u00fan el cuadro anterior. Agitar suavemente \u2014 no <strong>ajuste<\/strong> sacudir \u2014 y dejar reposar 5\u201310 minutos para su completa disoluci\u00f3n. La soluci\u00f3n debe ser transparente e incolora. <strong>Despu\u00e9s de la reconstituci\u00f3n:<\/strong> Conservar refrigerado a 2\u20138\u00a0\u00b0C y utilizar en un plazo de 30 d\u00edas. No congelar la soluci\u00f3n reconstituida. <\/p>\n<h2 id=\"faqs\">Preguntas frecuentes<\/h2>\n<h3>What is CJC-1295 without DAC used for in studies?<\/h3>\n<p>CJC-1295 without DAC (Mod GRF 1-29) is used in studies investigating pulsatile growth-hormone release, GHRH-receptor pharmacology, IGF-1 response kinetics, sleep architecture, body composition, and synergistic stacking with GHRP peptides such as ipamorelin. It is <strong>ajuste<\/strong> FDA-approved and is sold here strictly for clinical studies use only. <\/p>\n<h3>\u00bfCu\u00e1l es la diferencia entre el CJC-1295 con y sin DAC?<\/h3>\n<p>Both versions share the same core modified GHRH (1-29) sequence. The &#8220;with DAC&#8221; version has a maleimide group that binds covalently to serum albumin, extending plasma half-life from ~30 minutes to ~7 days. The &#8220;without DAC&#8221; version lacks this tether and retains the short half-life needed for pulsatile-protocols. Choice depends on whether the studies question requires sustained or pulsatile GHRH signaling. <\/p>\n<h3>What is the typical dose?<\/h3>\n<p>Los protocolos precl\u00ednicos publicados suelen utilizar 100\u2013200 mcg por administraci\u00f3n, 2\u20133 veces al d\u00eda. Un vial de 5 mg reconstituido con 2,0 mL de agua bacteriost\u00e1tica produce 2,5 mg\/mL \u2014 4 marcas en una jeringa U-100 proporcionan 100 mcg. <\/p>\n<h3>\u00bfEst\u00e1 aprobado el CJC-1295 sin DAC por la FDA?<\/h3>\n<p>No. Neither the with-DAC nor without-DAC version of CJC-1295 has received FDA, EMA, or any regulatory approval. Original development by ConjuChem was discontinued. All CJC-1295 sold by specialist suppliers is for clinical investigation only. <\/p>\n<h3>Why would I choose &#8220;without DAC&#8221; over &#8220;with DAC&#8221; in studies?<\/h3>\n<p>&#8220;Without DAC&#8221; is preferred when the studies question involves pulsatile physiological GH signaling, same-pulse ipamorelin stacking (both peptides timed together), or sleep-architecture studies where pre-sleep dosing needs to align with the natural nocturnal GH surge. &#8220;With DAC&#8221; is preferred for sustained-IGF-1 elevation studies and simpler weekly dosing. <\/p>\n<h3>\u00bfC\u00f3mo se debe almacenar el CJC-1295 sin DAC?<\/h3>\n<p>Viales liofilizados: refrigerados a 2\u20138\u00a0\u00b0C en el envase original, estable hasta 36 meses. Soluci\u00f3n reconstituida: refrigerada a 2\u20138\u00a0\u00b0C, utilizar en un plazo de 30 d\u00edas. No congelar la soluci\u00f3n reconstituida. <\/p>\n<h3>\u00bfC\u00f3mo reconstituyo el CJC-1295 sin DAC?<\/h3>\n<p>Sigue la tabla de reconstituci\u00f3n anterior. A\u00f1ade agua bacteriost\u00e1tica por la pared lateral del vial, agita suavemente y deja reposar entre 5 y 10 minutos para una disoluci\u00f3n completa. No <strong>ajuste<\/strong> agites. <\/p>\n<h3>\u00bfDebo combinar el CJC-1295 sin DAC con ipamorelina?<\/h3>\n<p>Yes \u2014 this is the canonical GH-axis stack for pulsatile-signaling studies. Both peptides are typically dosed together 2\u20133x daily; the short half-lives of both align so that each administration produces a same-pulse synergistic GH release. See our <a href=\"https:\/\/medsbase.com\/es\/ipamorelin-cjc-1295-stack-guide\/\">gu\u00eda de combinaciones<\/a>. <\/p>\n<h3>\u00bfQu\u00e9 concentraciones tiene MedsBase en stock?<\/h3>\n<p>MedsBase carries CJC-1295 without DAC in 2\u00a0mg, 5\u00a0mg, and 10\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis on request. <\/p>\n<h3>Does CJC-1295 without DAC cause side reported effects?<\/h3>\n<p>Published preclinical studies has reported a reasonable safety profile at typical doses. The most commonly reported observation is transient injection-site redness. Long-term human safety data are not available. Because the pulsatile kinetics are closer to native GHRH than the DAC version, some users consider this form more physiologically consistent. <\/p>\n<h3>\u00bfCu\u00e1l es la vida media de CJC-1295 sin DAC?<\/h3>\n<p>CJC-1295 sin DAC (GRF(1-29) modificado) tiene una vida media plasm\u00e1tica de aproximadamente 30 minutos \u2014 extendida respecto a los ~7 minutos de la GHRH(1-29) nativa mediante cuatro sustituciones de amino\u00e1cidos que protegen contra la degradaci\u00f3n enzim\u00e1tica. Esta vida media moderada produce un patr\u00f3n de liberaci\u00f3n puls\u00e1til de GH, haci\u00e9ndolo m\u00e1s fisiol\u00f3gicamente similar a la se\u00f1alizaci\u00f3n end\u00f3gena de GHRH que la forma DAC de acci\u00f3n prolongada. <\/p>\n<h3>\u00bfPor qu\u00e9 elegir CJC-1295 sin DAC sobre la versi\u00f3n DAC?<\/h3>\n<p>CJC-1295 without DAC preserves a pulsatile GH secretion pattern similar to endogenous GHRH physiology. Study protocols prioritising physiological pulsatility \u2014 particularly when stacking with a GHRP like Ipamorelin \u2014 typically use the no-DAC form. The DAC version is favoured in studies requiring maximal GH area-under-the-curve with less frequent administration. <\/p>\n<h3>\u00bfPuedo pedir CJC-1295 sin DAC para env\u00edo internacional?<\/h3>\n<p>S\u00ed. MedsBase env\u00eda CJC-1295 sin DAC a todo el mundo desde nuestra red de env\u00edos dedicada a p\u00e9ptidos. Los pedidos que solo contienen p\u00e9ptidos califican para nuestro servicio de env\u00edo independiente de p\u00e9ptidos. Los pedidos se env\u00edan en embalaje con control de temperatura y seguimiento completo. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/es\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/es\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 soft tissue and vascular recovery<\/li>\n<li><a href=\"\/es\/ipamorelin\/\"><strong>Ipamorelina<\/strong><\/a> \u2014 Agonista selectivo de grelina \u2014 pulso de GH limpio sin cortisol\/prolactina<\/li>\n<li><a href=\"\/es\/cjc-1295-with-dac\/\"><strong>CJC-1295 con DAC<\/strong><\/a> \u2014 An\u00e1logo de GHRH con vida media extendida<\/li>\n<li><a href=\"\/es\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Lecturas adicionales<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Lee nuestra gu\u00eda completa basada en evidencia: <a href=\"https:\/\/medsbase.com\/es\/ipamorelin-cjc-1295-stack-guide\/\"><strong>Ipamorelin &amp; CJC-1295 \u2014 mecanismo, combinaci\u00f3n y protocolos<\/strong><\/a>. Cubre la farmacolog\u00eda de GHRH puls\u00e1til vs sostenida, las diferencias cin\u00e9ticas DAC vs sin DAC, los protocolos de combinaci\u00f3n can\u00f3nicos, la reconstituci\u00f3n y las notas de seguridad.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Favorece la se\u00f1alizaci\u00f3n de crecimiento<br \/>\n\u2705 Mejora la regulaci\u00f3n metab\u00f3lica<br \/>\n\u2705 Favorece la regeneraci\u00f3n tisular<br \/>\n\u2705 Optimiza las v\u00edas de recuperaci\u00f3n<br \/>\n\u2705 Potencia el equilibrio hormonal<\/p>\n<p><strong>CJC-1295 con DAC<\/strong> contiene compuesto de p\u00e9ptido sint\u00e9tico.<\/p>","protected":false},"featured_media":70945,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5471],"class_list":["post-69005","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-cjc-1295-without-dac","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product\/69005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/comments?post=69005"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media\/70945"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media?parent=69005"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_brand?post=69005"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_cat?post=69005"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_tag?post=69005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}